Psychosocial Pain Management During Addictions Treatment to Improve Outcomes

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT01372267
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
510
1
2
66
7.7

Study Details

Study Description

Brief Summary

The present intervention is a Stage II randomized controlled efficacy trial of a group-based intervention that integrates Cognitive Behavioral Therapy (CBT) for pain and substance use disorders (SUDs) compared to a Supportive Psychoeducation Control (SPC) group in a sample of patients receiving residential SUD treatment with co-occurring chronic pain. A total of 452 patients (226 male and 226 female) with current pain rated as moderately severe or greater and comorbid drug or alcohol use disorder(s) will be recruited from a large residential SUD treatment program. These participants will be randomly assigned to either a 4-week (8-session) group of integrated CBT for pain and SUDs or a 4-week (8-session) SPC group. All participants will be re-assessed immediately post-treatment (1 month) and again at 3, 6, and 12 months post-intervention. Through this randomized controlled trial, the investigators hope to gain insight on how to improved treatment of pain in those with SUDs that could result in enhanced quality of life and improved pain-related, substance use, and other health outcomes. Evaluating a psychosocial intervention for pain and substance use that can be delivered during a SUD treatment episode would significantly extend available treatment options for the large numbers of patients with pain seen by SUD treatment providers. The investigators also hope to determine the efficacy of an evidence-based psychosocial pain management approach in men and women from a large and diverse residential addiction treatment program.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Psychoeducation for substance abuse
  • Behavioral: CBT for pain in Substance abuse
N/A

Detailed Description

Chronic pain among individuals who misuse drugs or alcohol is a common and critically important problem that is rarely managed appropriately. The estimated rates of chronic pain in Substance Use Disorder (SUD) treatment are as high as 60%. Chronic pain is seldom successfully addressed in SUD treatment settings because of a limited understanding of the problem and a lack of effective intervention strategies. A clear and urgent need exists for the study of effective alternatives to the use of opiate pain medications in those treated for SUDs who also have pain because of: (1) the potential for abuse and diversion of opiate medications by patients in SUD treatment; and (2) recent evidence that untreated pain may undermine the effectiveness of standard treatments for SUDs.

An important potential strategy to address this problem is the use of Cognitive Behavioral Therapy (CBT) to manage pain and decrease substance misuse. Psychosocial interventions such as CBT have demonstrated efficacy for reducing pain and improving functioning for a broad spectrum of pain-related conditions. However, this form of treatment has not been explicitly tested in patients with co-occurring substance use disorders. Additionally, although pain is common in both men and women, most studies have lacked sufficient power to test the effect of interventions separately in men and women. The present intervention is designed to integrate CBT for pain and CBT for SUDs with the primary goal of improving pain- and substance-related outcomes. The investigators will test the efficacy of this modified protocol on both men and women in this understudied patient population.

Study Design

Study Type:
Interventional
Actual Enrollment :
510 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Study Start Date :
Oct 1, 2011
Actual Primary Completion Date :
Jan 1, 2016
Actual Study Completion Date :
Apr 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: CBT for pain

Behavioral: CBT for pain in Substance abuse
The therapeutic intervention group is designed to provide beneficial coping strategies that are helpful in dealing with both substance use and pain.

Active Comparator: Psychoeducational control group

This group is designed to be an active control which provides detailed information about substance us and chronic pain without providing any CBT or other specific therapy.

Behavioral: Psychoeducation for substance abuse
This active control provides detailed educational information about substance use and chronic pain to those enrolled.

Outcome Measures

Primary Outcome Measures

  1. Change in level of pain [Baseline, one, three, six, twelve months]

    For each follow-up time point, we will subtract the baseline value to obtain a change score

  2. Change in pain tolerance [Baseline, one, three, six, twelve months]

    For each follow-up time point, we will subtract the baseline value to obtain a change score

  3. Change in pain-related functioning [Baseline, one, three, six, twelve months]

    For each follow-up time point, we will subtract the baseline value to obtain a change score

Secondary Outcome Measures

  1. Change in Substance use [Baseline, three, six, twelve months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Must be over 18 years of age

  • Report moderate to severe pain over past 3 months

  • Resided in treatment for less than 60 days

Exclusion Criteria:
  • Acute suicidality

  • Mental incompetence (e.g. unable to provide informed consent)

  • Evidence of current psychosis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Community Programs, INC. Waterford Michigan United States 48327

Sponsors and Collaborators

  • University of Michigan
  • National Institute on Drug Abuse (NIDA)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mark A. Ilgen, Associate Professor of Psychiatry, Medical School, University of Michigan
ClinicalTrials.gov Identifier:
NCT01372267
Other Study ID Numbers:
  • 1R01DA029587-01A1
First Posted:
Jun 13, 2011
Last Update Posted:
Jul 24, 2017
Last Verified:
Jul 1, 2017
Keywords provided by Mark A. Ilgen, Associate Professor of Psychiatry, Medical School, University of Michigan

Study Results

No Results Posted as of Jul 24, 2017